Yuzun International
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Yuzun International - overview
Established
2023
Location
Haikou, Hainan, China
Primary Industry
Biotechnology
About
Based in Haikou, China and founded in 2023, Hainan Yuzun International Biotechnology Research and Experimental Development Co. , Ltd. , trading as Yuzun International, is a life science technology R&D and commercialization service provider. In February 2026, Yuzun International raised CNY 280 million in series A funding.
The company focuses on cutting-edge fields such as biomedicine, gene editing, and cell therapy since its inception, providing technical services covering the entire chain from R&D to experimentation and commercialization. The company's revenue is generated by providing technical services covering the entire chain from R&D to experimentation and commercialization. The company will use the funding to accelerate the construction of the company's core R&D platform, expand international clinical trial cooperation, and attract top global scientific research talent.
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.